Lightcalls.com
 

Do vitamin cogitation flip-flops h...

Do vitamin cogitation flip-flops have you totally confused? To help you sort things gone out we've scrutinized the research and weighed the conflicting evidence. And now, we're confused too.

If you take vitamin E to ward against heart disease, you were likely assaulted by the study published June 14 in The Lancet. Researchers reported that vitamin E capsules have no result on the risk of death from cardiovascular disease--or forward the risk of death from any other cause, for that matter.

likewise is vitamin E a waste of time and money? The answer is simple. Ye and no.

The numerous patients studied indicated a certain quantity of risk factor for a pre-cardiac condition. In other words, they weren't necessarily released of heart disease. So the thought suggests that if you already have heart disease, taking vitamin E won't extend your life.

yet if you have a healthy heart, will long-term vitamin E supplementation actually maintain you from acquiring cardiovascular disease? OK that we still don't know.



Right Is Wrong

Meanwhile, adroits say vitamin E ingested in the form of feed is absorbed much more readily than from capsules. in like manner we should eat more walnuts and other E-rich victualss right? Right. And then, we wouldn't ne vitamin E capsules, right? Wrong

The National Academy of Sciences (NAS) says we don't ne fill ups if we're getting a minimum of 15 milligrams (mg) of vitamin E a day--as lengthy as that intake is coming from better-absorbed viands sources. The catch? The NAS also says greatest in quantity people get only half that amount from their diets.

to such a degree unless you double your intake of vitamin E-rich nutritions there's only one answer: vitamin E capsules.

yet vitamin E won't help with whiplash--which many readers got doing a double-take after a large cogitation on seniors appeared July 6 2002 also in The Lancet.

Oxford University researchers place that taking several different antioxidant vitamins--C, E and beta-carotene--produces no health event So these vitamins are useless? Well, not exactly.

Doses were too small for an effective ordeal The 250 mg dose of vitamin C is too little to measure disease-prevention effects--except maybe for scurvy

Also, the consideration was not conducted over a in extent enough period of time. Finally, sole seniors participated in the study

one as well as the other and Neither

yet then a similar study appeared 2 days later. In the July 8 2002 issue of the Archives of Internal Medicine, researchers erect that vitamins E and C and multivitamins do not bring to heart-related deaths. So these add tos don't help the heart, right? Let's back up a bit.

Oxidation of fat particles in the life-current leads to hardening of the arteries. Antioxidants retard this process

Numerous lab standards animal studies and a few--unfortunately small--human studies confirm this benefit, especially in the case of vitamin E

Also, a close attention in the June 26, 2002 Journal of the American Medical Association (JAMA) conclud that "high dietary intake of vitamins C and E may lower the risk of Alzheimer's." in the same manner at least for Alzheimer's, vitamin pills work, right?

Well, not necessarily. You behold this study referred to "dietary intake"--in other words, vitamins build in food. So the application of mind does not mean that Alzheimer's risk can be obstructed by vitamin supplements. Then again, a thought in the June 29, 2002 JAMA--yup, just 3 days later--concluded that vitamin E appendixs actually do, indeed, decrease the risk of Alzheimer's disease.

Maybe these sum of two units teams should compare notes--you know, memorize fax machines.

Previous studies showing health benefits from vitamin appendixs were, admittedly, smaller samplings. if it be not that they also used longer bourns or higher doses. And that's a crucial difference.

Definitely Perhaps

With in like manner much confusion, scientists analyzed all vitamin studies from 1966 between the walls of January 2002 to see which way the wind beats Their June 19, 2002 JAMA meta-study--yes, that's three studies in the same month--conclud "Some are at higher risk for sub-optimal vitamin status ... linked to coronary heart disease, cancer and osteoporosis." That insinuates vitamins are needed for insurance against these diseases. Think that clears things up? Scientists also say there's no proven benefit from taking vitamins as insurance. And a June 24 2003 JAMA reflection reported increased osteoporosis risk from the couple too much vitamin A--and too little.

That July 6 2002 autioxidant thought in The Lancet concluded we should realize vitamins from produce, not pills. moreover hold the phone.

onward July 5, 2002--a day earlier--Canadian scientists reported that vitamin A contentment in produce has plummeted 68 percent in 50 years. Iron ease dropped by 76 percent, among others.

recent farming is cited as the culprit. You'll ne six oranges to earn the nutrition of one orange from the past--unless it's been in your fridge since the 1950 Without complements you'd need to eat a whole chance more to get the same vitamins.

A Solid Maybe

if it were not that something nags me about increasing provender intake, as I sit here upon stacks of studies about rampant obesity. Obesity increases the risk of--you solveed it--cancer and heart disease.



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.